Recro provides oral solid dosage form development, regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. Specializing in modified release oral solid dose and DEA controlled substances, Recro has the experts to deliver clients’ most complex pharmaceutical development and manufacturing projects in its best-in-class facilities, totaling 120,000 square feet. For more information about Recro’s flexible CDMO solutions, visit
recrogainesville.com.